# Umbilical Cord Blood-Supported Haplo-HSCT for Aplastic Anemia Treatment Study

> **NCT06650553** · NA · RECRUITING · sponsor: **Shanxi Bethune Hospital** · enrollment: 110 (estimated)

## Conditions studied

- Aplastic Anemias

## Interventions

- **PROCEDURE:** Clinically diagnosed AA patients are divided into HLA-matched HSCT group and umbilical cord blood-supported haplo-HSCT group.

## Key facts

- **NCT ID:** NCT06650553
- **Lead sponsor:** Shanxi Bethune Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-01
- **Primary completion:** 2027-06
- **Final completion:** 2027-07
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2025-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06650553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06650553, "Umbilical Cord Blood-Supported Haplo-HSCT for Aplastic Anemia Treatment Study". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06650553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*